The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
NCT01691781
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Hyperparathyroidism
Interventions
DRUG:
Lisinopril
Sponsor
Brigham and Women's Hospital